DaShenLin Pharmaceutical Group Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 14,582.865 million compared to CNY 11,141.165 million a year ago. Operating income was CNY 1,447.962 million compared to CNY 918.256 million a year ago. Net income was CNY 1,062.181 million compared to CNY 702.661 million a year ago. Basic earnings per share from continuing operations was CNY 1.62 compared to CNY 1.11 a year ago. Diluted earnings per share from continuing operations was CNY 1.62 compared to CNY 1.1 a year ago.